Quick Summary
Click here for Price and Turnaround Time
Phenotype: Hereditary equine regional dermal asthenia (HERDA) is an inherited skin disease characterized by hyperextensible skin, scarring, and severe lesions along the back of affected horses.
Mode of Inheritance: Autosomal recessive
Alleles: N = Normal/Unaffected, HRD = Hereditary equine regional dermal asthenia
Breeds appropriate for testing: Quarter Horse and related breeds
Explanation of Results:
- Horses with N/N genotype will not have hereditary equine regional dermal asthenia and cannot transmit this hereditary equine regional dermal asthenia variant to their offspring.
- Horses with N/HRD genotype will not be affected by hereditary equine regional dermal asthenia, but are carriers. They may transmit this hereditary equine regional dermal asthenia variant to 50% of their offspring. Matings between two carriers result in a 25% chance of producing an affected foal.
- Horses with HRD/HRD genotype will have hereditary equine regional dermal asthenia.
$45 one test per animal
+ $15 each additional test from list below:
- Glycogen Branching Enzyme Deficiency (GBED)
- Hyperkalemic Periodic Paralysis (HYPP)
- Myosin-Heavy Chain Myopathy (MYHM)
- Malignant Hyperthermia (MH)
- Polysaccharide Storage Myopathy (PSSM1)
$100 entire Quarter Horse & Related Breeds Disease Panel (5-panel plus) (all 6 tests)
Quarter Horse & Related Breeds Disease Panel (5-panel plus)
$100 per animal
AQHA recording fee may apply
Sample Collection
Horse DNA tests are carried out using cells from the roots of a hair sample (roughly 20-30 hairs).
1. Grab about 10 hairs at the base.
2. Wrap the hairs around your finger and give it a quick pull.
3. Check the ends to make sure the pulled hairs have roots.
4. Repeat the process until you have collected about 20-30 hairs with intact roots.
5. You can choose different places on the mane or tail. NOTE: For foals, we recommend pulling all hairs from the tail only.
6. Tape the hairs to the submission form and fold the form along the dotted line to protect the sample. Do not use ziploc bags as they can cause condensation that allows mold to grow on the hair.
7. Place the folded form containing the sample in a paper envelope and mail it to the laboratory.
Hereditary equine regional dermal asthenia (HERDA) is a genetic skin disease predominantly found in the American Quarter Horse. Within the breed, the disease is prevalent in particular lines of cutting horses. HERDA is characterized by hyperextensible skin, scarring, and severe lesions along the back of affected horses. Affected foals rarely show symptoms at birth. The condition typically occurs by the age of two, most notably when the horse is first being broke to saddle. There is no cure, and the majority of diagnosed horses are euthanized because they are unable to be ridden and are inappropriate for future breeding.
HERDA has an autosomal recessive mode of inheritance and affects stallions and mares in equal proportions. Research carried out in Dr. Danika Bannasch's laboratory at the University of California, Davis, identified the mutation causing HERDA. HERDA is caused by a single base change in the gene PPIB (c.115G>A). This missense mutation codes for a change in the gene product, specifically the normal glycine at position 39 is changed to an arginine (denoted as p.G39R) altering the Peptidylprolyl Isomerase B (PRIB) protein. PPIB is one of the proteins involved in proper collagen formation. Collagen is is an important structural protein of all connective tissues including skin. Functional studies have shown that the HERDA mutation delays proper collagen folding and secretion and is presumed to alter collagen organization thus leading to the clinical manifestations.
This diagnostic DNA test for HERDA allows identification of horses that are affected or that carry the specific mutation. Other skin conditions can mimic the symptoms of HERDA; this DNA test will assist veterinarians to make the correct diagnosis. For horse breeders, identification of carriers is critical for the selection of mating pairs. Breedings of carrier horses have a 25% chance of producing an affected foal. Breedings between normal and carrier horses will not produce a HERDA foal, although 50% of the foals from this type of cross are expected to be carriers.